These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 15073899

  • 1. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.
    Prescott P, Bakowski MT.
    Pharmacoepidemiol Drug Saf; 1999 Oct; 8(6):377-84. PubMed ID: 15073899
    [Abstract] [Full Text] [Related]

  • 2. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.
    N Engl J Med; 1997 May 01; 336(18):1283-9. PubMed ID: 9113931
    [Abstract] [Full Text] [Related]

  • 4. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.
    Bakowski MT, Prescott P.
    Pharmacoepidemiol Drug Saf; 1997 Sep 01; 6(5):347-58. PubMed ID: 15073770
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC, Maguiness KM, Hollingsworth J, Heilman DK, Chong SK.
    J Pediatr Gastroenterol Nutr; 1998 Jan 01; 26(1):80-4. PubMed ID: 9443125
    [Abstract] [Full Text] [Related]

  • 6. Fibrosing Colonopathy Presenting in a Patient with Cystinosis.
    Fiore D, Sohini V, Mileti E, Fiore N.
    JPGN Rep; 2023 Aug 01; 4(3):e321. PubMed ID: 37600607
    [Abstract] [Full Text] [Related]

  • 7. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
    Mack EH, Brett AS, Brown D.
    South Med J; 2004 Sep 01; 97(9):901-4. PubMed ID: 15455984
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM, Wolfe SP, Conway SP.
    Pediatr Pulmonol; 2006 Jan 01; 41(1):35-49. PubMed ID: 16288483
    [Abstract] [Full Text] [Related]

  • 9. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL.
    Pediatr Dev Pathol; 1998 Jan 01; 1(1):74-8. PubMed ID: 10463274
    [Abstract] [Full Text] [Related]

  • 10. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.
    Aliment Pharmacol Ther; 2004 Dec 01; 20(11-12):1365-71. PubMed ID: 15606399
    [Abstract] [Full Text] [Related]

  • 11. First adult patient with fibrosing colonopathy.
    Häusler M, Meilicke R, Biesterfeld S, Heimann G.
    Am J Gastroenterol; 1998 Jul 01; 93(7):1171-2. PubMed ID: 9672356
    [Abstract] [Full Text] [Related]

  • 12. Is fibrosing colonopathy an immune mediated disease?
    Lee J, Ip W, Durie P.
    Arch Dis Child; 1997 Jul 01; 77(1):66-70. PubMed ID: 9279159
    [Abstract] [Full Text] [Related]

  • 13. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.
    Lloyd-Still JD, Uhing MR, Arango V, Fusaro A, Kimura RE.
    J Pediatr Gastroenterol Nutr; 1998 May 01; 26(5):489-95. PubMed ID: 9586757
    [Abstract] [Full Text] [Related]

  • 14. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements.
    Bansi DS, Price A, Russell C, Sarner M.
    Gut; 2000 Feb 01; 46(2):283-5. PubMed ID: 10644326
    [Abstract] [Full Text] [Related]

  • 15. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr 01; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 16. Clinical quiz. Diagnosis: fibrosing colonopathy.
    Monroe L, Nowicki M, Giles H, Ruiz F.
    J Pediatr Gastroenterol Nutr; 2006 Mar 01; 42(3):339-41. PubMed ID: 16540809
    [No Abstract] [Full Text] [Related]

  • 17. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug 01; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 18. Fibrosing colonopathy in a man with cystic fibrosis on pancreatic enzyme supplements.
    Jain S, Subramony C, Blanchard K, Petro M, Minocha A.
    Indian J Gastroenterol; 2005 Aug 01; 24(6):238. PubMed ID: 16424618
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of emodin on pancreatic fibrosis: experiment with rats].
    Wang CH, Gao ZQ, Ye B, Xie CG, Qian KD, Cai JT, Du Q.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 26; 86(36):2552-5. PubMed ID: 17198564
    [Abstract] [Full Text] [Related]

  • 20. Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate.
    Int J Toxicol; 2007 Sep 26; 26 Suppl 3():31-77. PubMed ID: 18080873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.